Description
Cabazitaxel N-1 is an intermediate in the synthesis of the anti-cancer compound cabazitaxel.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Cabazitaxel N-1 is an intermediate in the synthesis of the anti-cancer compound cabazitaxel.
| Cas No. | 1354900-66-5 |
|---|---|
| Purity | ≥95% |
| Formula | C53H63NO15 |
| Formula Wt. | 954.08 |
| IUPAC Name | 5-O-[(1S,4S,10S)-4-acetyloxy-2-benzoyloxy-1-hydroxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-15-yl] 3-O-tert-butyl 2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-3,5-dicarboxylate |
| Synonym | (4S,5R)-2-(4-Methoxyphenyl)-4-phenyl-3,5-oxazolidinedicarboxylic acid 5-[(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl] 3-(1,1-dimethylethyl) ester |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Found in Piper longum; TxA2 antagonist, ubiquit...
Peptide, vSrc-induced cytokine.
TRPM8 activator, TRPV3 blocker.
Endogenous tachykinin peptide, involved in infl...
Mcl-1 inhibitor
Non-opioid analgesic.
p110α PI3K and mTOR inhibitor.
Calcium channel blocker.
STING activator
Piperazine; FIASMA, D2 antagonist, hERG K+ chan...
Histamine H1 antagonist, FIASMA.
Tricyclic benzonaphthyridinone; mTORC1/2 inhibi...
Phallotoxin found in Amanita phalloides; microt...
LRRK2 inhibitor.
Mycotoxin metabolite
Type A trichothecene mycotoxin produced by Fusa...
Curcumin derivative; AMPK activator, STAT3 and ...
Furan derivative.
Thrombin substrate used to measure thrombin act...
Essential fatty acid found in fish oil, involve...